Shares of OpGen, Inc. (OTC:OPGN – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $11.01 and traded as high as $20.00. OpGen shares last traded at $18.81, with a volume of 2,305 shares trading hands.
OpGen Price Performance
The stock has a 50 day simple moving average of $11.28 and a 200-day simple moving average of $5.62. The firm has a market cap of $182.18 million, a PE ratio of -3.25 and a beta of -1.77.
About OpGen
OpGen, Inc (NASDAQ: OPGN) is a precision medicine company specializing in molecular diagnostics and digital solutions for infectious disease management. Leveraging next-generation sequencing, bioinformatics and molecular assay technologies, OpGen develops tools designed to detect microbial pathogens and antimicrobial resistance markers rapidly and accurately. The company’s mission is to support clinicians and laboratories in making timely, informed treatment decisions that help curb the spread of drug-resistant infections.
Among OpGen’s key offerings is the Acuitas® AMR Gene Panel, a suite of molecular assays that identify genetic determinants of antibiotic resistance directly from positive blood cultures.
Featured Stories
- Five stocks we like better than OpGen
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
